Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 17.00
+0.60 (3.66%)
At close: Jul 17, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €127.78 million as of July 17, 2026. Its market cap has increased by 246.58% in one year.
Market Cap
127.78M
Enterprise Value
125.58M
Revenue
9.69M
Ranking
n/a
PE Ratio
44.11
Stock Price
€17.00
ChartMarket Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 127.78M, an increase of 731.43%. That is a compound annual growth rate of 62.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 127.78M | 98.63% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.44B |
| Laboratorios Farmaceuticos Rovi | 2.75B |
| Almirall | 2.32B |
| Faes Farma | 1.35B |
| Clínica Baviera | 922.67M |
| Oryzon Genomics | 237.02M |
| Prim, S.A. | 226.28M |
| Laboratorio Reig Jofre | 215.74M |